CETPi Forum

register login
  • Skip to content
  • Homesummary
  • About CETPi Forum 
  • News 
    • News
    • Meeting reports
    • Forthcoming Meetings
  • Resources 
    • Slides
    • Societies
    • Guidelines
    • Links
    • Glossary
  • Ask the Expert 
    • Viewpoints
  • CETPi Essentials 
    • About CETPi Forum
    • About HDL Forum
  • Register 
  • Contact 
Click on the slide!
Click on the slide!
Click on the slide!
Click on the slide!
  • «
  • Click to navigate! 01 Latest News
  • Click to navigate! 02 Viewpoints
  • Click to navigate! 03 Resources
  • Click to navigate! 04 Forthcoming Meetings
  • »
  • Pause
Frontpage Slideshow (version 2.0.0) - Copyright © 2006-2008 by JoomlaWorks

What's New

  • New insights into CETP mechanism
  • CETP inhibition after dalcetrapib? A perspective from the HDL Forum Editors
  • Dalcetrapib trial DAL-VESSEL published in European Heart Journal
  • CETP inhibition improves postprandial HDL2 functionality
  • Persistence of anacetrapib lipid effects post- therapy
  • News for evacetrapib, a novel CETP inhibitor

Viewpoints

Expert Opinion: Focus on HDL

Professor Philip Barter, Director, The Heart Research Institute, Sydney, Australia discusses key issues including:

  • Potential role of HDL as a therapeutic target
  • HDL and insulin resistance
  • Relevance of apoA-I
  • Emerging HDL therapies
  • Residual cardiovascular risk
  • Watch the video here

Watch the video here

Hot Topic

Discussion of critical clinical and scientific questions by key opinion leaders

Messages from dal-PLAQUE

Professor Zahi Fayad,
Mount Sinai Medical School, New York, USA and lead investigator talks to CETPi Forum at ESC 2011

Forthcoming Meetings

13-16 March, 2012: 4th International Singapore Lipid Symposium (ISLS)
Singapore
More Information

24-27 March, 2012: ACC12
Chicago, USA
More Information

25-29 March, 2012: XVI International Symposium on Atherosclerosis (ISA2012)
Sydney, Australia
More Information

30 March-1 April 2012: HDL Satellite Symposium 2012
Cairns, Tropical North Queensland, Australia
More Information

18-20 April, 2012: ATVB 2012
Chicago, USA
More Information

Editors

  • Professor Kerry-Anne Rye

    Head of Lipid Research Group
    Read more...


  • Professor Philip Barter

    Director
    Read more...


  • Professor John Chapman

    Director
    Read more...

     

     

    Click Here for the Editorial Board

REGISTRATION IS FREE TO ALL HEALTHCARE PROFESSIONALS

 Supported by unrestricted medical
educational grants from

 Supporters have no editorial influence
over the content of this website

Unless otherwise indicated, opinions expressed in HDL Forum are those of the contributors.  Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the sponsor, publisher, editors or the editorial board is accepted for the consequences of any misleading or inaccurate information.

© 2012 . All rights reserved.



  • Forgot your password?
  • Forgot your username?
  • Create an account